Beta Capital has invested in Nutrium, a University of Minho start-up specializing in technological solutions for nutrition, as part of their Beta Innovation fund, focusing on R&D-driven companies.

Information on the Target

Nutrium is a technological start-up that originated from the University of Minho. The company focuses on developing innovative solutions in the nutraceutical and dietary sectors, leveraging research and development to create products that enhance health and well-being. With a strong foundation in academic research, Nutrium aims to bridge the gap between scientific knowledge and practical applications in nutrition.

As part of its growth strategy, Nutrium seeks to expand its reach and impact by integrating advanced technology in dietary management and nutritional planning. The company's commitment to R&D positions it well in the rapidly evolving health tech landscape, making it an attractive investment opportunity.

Industry Overview in Portugal

The health technology sector in Portugal has witnessed significant growth over recent years, driven by increasing consumer awareness around health and nutrition. As the demand for personalized health solutions rises, companies like N

View Source

Similar Deals

BioNTech SE CellmAbs S.A.

2024

Other VC Bio Therapeutic Drugs Portugal
Beta Capital Matera

2021

Other VC Biotechnology & Medical Research (NEC) Portugal
Industrifonden Zymego

2026

Other VC Healthcare Facilities & Services (NEC) Sweden
Unknown Aeon

2025

Other VC Medical & Diagnostic Laboratories Other
3xP Global Mezze Lda

2025

Other VC Civic & Social Organizations Portugal
GOCA3 Technologie de mesure de fluidité membranaire

2025

Other VC Bio Diagnostics & Testing Other

Beta Capital

invested in

Nutrium

in 2023

in a Other VC deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert